Dr. Raolat Abdulai Appointed As Chief Medical Officer At Galvani Bioelectronics

Jul 17, 2024•about 1 year ago

Position

Chief Medical Officer

Company

Galvani Bioelectronics

Raolat Abdulai

HertfordshireMedicalBiotechnologyHealth Care

Description

Galvani Bioelectronics is recruiting for a randomized, controlled stage of a clinical feasibility study for patients with Rheumatoid Arthritis (RA) and has received approval from the US Food and Drug Administration (FDA) for this progression. Dr. Raolat Abdulai is joining the company as Chief Medical Officer in August.

Company Information

Company

Galvani Bioelectronics

Location

Hertfordshire, England, United Kingdom

About

Galvani Bioelectronics is a pioneering research and development company dedicated to bringing bioelectronic therapies to patients. The company was formed through a partnership between two global healthcare companies, GSK and Verily Life Sciences, a subsidiary of Alphabet Inc. Galvani is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

FundzWatch™ Score

Medium Activity

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months